Actively Recruiting
STarting incrEmental Prescription of Peritoneal Dialysis
Led by The University of Queensland · Updated on 2026-03-19
224
Participants Needed
6
Research Sites
210 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.
CONDITIONS
Official Title
STarting incrEmental Prescription of Peritoneal Dialysis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older starting peritoneal dialysis as their first dialysis therapy
- On dialysis for less than 1 month
- Able to give informed consent
You will not qualify if you...
- Urine output less than 0.5 liters per day
- Previous kidney transplant
- Unlikely to remain on dialysis for at least 1 year
- Known or planned pregnancy during the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Blacktown
Blacktown, New South Wales, Australia, 2148
Actively Recruiting
2
Princess Alexandra Hospital
Brisbane, Queensland, Australia, 4102
Not Yet Recruiting
3
Eastern Health
Box Hill, Victoria, Australia, 3218
Actively Recruiting
4
Hallym University Sacred Heart Hospital
Chuncheon, Gangwon-do, South Korea, 14068
Actively Recruiting
5
Taichung Veterans General Hospital
Taichung, Xitun District, Taiwan, 1650
Actively Recruiting
6
King Chulalongkorn Memorial Hospital
Bangkok, Pathum Wan, Thailand, 10330
Actively Recruiting
Research Team
P
Professor Yeoungjee Cho
CONTACT
L
Laura Hickey
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here